Clinica Colsanitas S.A, Sede Clínica Universitaria Colombia-Center Investigator ( Site 2500)

Bogotá, Bogota D.C. 111321

0 studies enrolling now · 1 studies all time

What they study most

Melanoma

Studies at this site

• A Clinical Study of Intismeran Autogene (V940) Plus Pembrolizumab in People With High-Risk Melanoma (V940-001) — Running, not enrolling